Cindy Geoghegan

1.4k total citations
19 papers, 631 citations indexed

About

Cindy Geoghegan is a scholar working on General Health Professions, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Cindy Geoghegan has authored 19 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in General Health Professions, 7 papers in Oncology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Cindy Geoghegan's work include Mobile Health and mHealth Applications (6 papers), Digital Mental Health Interventions (5 papers) and Bone health and treatments (3 papers). Cindy Geoghegan is often cited by papers focused on Mobile Health and mHealth Applications (6 papers), Digital Mental Health Interventions (5 papers) and Bone health and treatments (3 papers). Cindy Geoghegan collaborates with scholars based in United States, United Kingdom and Canada. Cindy Geoghegan's co-authors include J. Sybil Biermann, Jamie H. Von Roenn, Sarah Temin, William E. Barlow, Nora A. Janjan, Gary C. Yee, Linda D. Bosserman, Catherine Van Poznak, Richard L. Theriault and Bruce E. Hillner and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Reviews Drug Discovery.

In The Last Decade

Cindy Geoghegan

18 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cindy Geoghegan United States 10 338 120 101 99 86 19 631
Érick Moyneur United States 16 242 0.7× 139 1.2× 78 0.8× 67 0.7× 60 0.7× 43 1.2k
Carol Stober Canada 16 257 0.8× 123 1.0× 88 0.9× 64 0.6× 49 0.6× 45 603
Jared C. Foster United States 12 364 1.1× 140 1.2× 80 0.8× 105 1.1× 26 0.3× 27 928
Maria Olsen Netherlands 12 318 0.9× 112 0.9× 92 0.9× 44 0.4× 94 1.1× 20 923
Christopher Wynne New Zealand 15 295 0.9× 147 1.2× 152 1.5× 126 1.3× 49 0.6× 35 740
Megan E.V. Caram United States 15 200 0.6× 255 2.1× 43 0.4× 56 0.6× 50 0.6× 73 580
Mary C. Schroeder United States 15 333 1.0× 150 1.3× 108 1.1× 86 0.9× 53 0.6× 61 801
Martijn Groot Netherlands 9 298 0.9× 110 0.9× 43 0.4× 50 0.5× 23 0.3× 12 507
Xinyu Wang China 14 117 0.3× 98 0.8× 48 0.5× 60 0.6× 30 0.3× 63 423

Countries citing papers authored by Cindy Geoghegan

Since Specialization
Citations

This map shows the geographic impact of Cindy Geoghegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy Geoghegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy Geoghegan more than expected).

Fields of papers citing papers by Cindy Geoghegan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy Geoghegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy Geoghegan. The network helps show where Cindy Geoghegan may publish in the future.

Co-authorship network of co-authors of Cindy Geoghegan

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy Geoghegan. A scholar is included among the top collaborators of Cindy Geoghegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy Geoghegan. Cindy Geoghegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Goldsack, Jennifer C., Cindy Geoghegan, Jorge J. Nieva, et al.. (2023). Advancing Digital Health Innovation in Oncology: Priorities for High-Value Digital Transformation in Cancer Care. Journal of Medical Internet Research. 25. e43404–e43404. 21 indexed citations
2.
Silberman, Jordan, Paul Wicks, Siyeon Park, et al.. (2023). Rigorous and rapid evidence assessment in digital health with the evidence DEFINED framework. npj Digital Medicine. 6(1). 101–101. 17 indexed citations
3.
Demanuele, Charmaine, Cynthia Lokker, Krishna A. Jhaveri, et al.. (2022). Considerations for Conducting Bring Your Own “Device” (BYOD) Clinical Studies. SHILAP Revista de lepidopterología. 6(2). 47–60. 23 indexed citations
4.
5.
Geoghegan, Cindy, et al.. (2020). Learning from patient and site perspectives to develop better digital health trials: Recommendations from the Clinical Trials Transformation Initiative. Contemporary Clinical Trials Communications. 19. 100636–100636. 8 indexed citations
6.
McKenna, Kevin, Cindy Geoghegan, Brian Perry, et al.. (2020). Investigator Experiences Using Mobile Technologies in Clinical Research: Qualitative Descriptive Study. JMIR mhealth and uhealth. 9(2). e19242–e19242. 8 indexed citations
7.
Carthy, Marie Mc, et al.. (2020). Determining Minimum Wear Time for Mobile Sensor Technology. Therapeutic Innovation & Regulatory Science. 55(1). 33–37. 5 indexed citations
8.
Stover, Angela M., Allison M. Deal, Jennifer Jansen, et al.. (2019). Development and testing of patient-reported outcome performance measures (PRO-PMs) for oncology practice.. Journal of Clinical Oncology. 37(27_suppl). 173–173. 1 indexed citations
9.
Perry, Brian, et al.. (2019). Patient preferences for using mobile technologies in clinical trials. Contemporary Clinical Trials Communications. 15. 100399–100399. 34 indexed citations
10.
Dalton, W. Brian, Patrick M. Forde, Hyunseok Kang, et al.. (2017). Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board. JCO Precision Oncology. 2017(1). 1–19. 53 indexed citations
11.
Basch, Ethan, Cindy Geoghegan, Stephen Joel Coons, et al.. (2015). Patient-Reported Outcomes in Cancer Drug Development and US Regulatory Review. JAMA Oncology. 1(3). 375–375. 105 indexed citations
12.
Geoghegan, Cindy, et al.. (2012). Abstract P6-08-09: Overcoming Breast Cancer: The Importance of Connecting with Fellow Survivors. Cancer Research. 72(24_Supplement). P6–8.
13.
Poznak, Catherine Van, Sarah Temin, Gary C. Yee, et al.. (2011). American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer. Journal of Clinical Oncology. 29(9). 1221–1227. 235 indexed citations
14.
McClellan, Mark, Joshua S. Benner, Richard L. Schilsky, et al.. (2011). An accelerated pathway for targeted cancer therapies. Nature Reviews Drug Discovery. 10(2). 79–80. 24 indexed citations
15.
Bruner, Deborah Watkins, Laura J. Hanisch, Bryce B. Reeve, et al.. (2011). Stakeholder perspectives on implementing the National Cancer Institute’s patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Translational Behavioral Medicine. 1(1). 110–122. 64 indexed citations
16.
Poznak, Catherine Van, William E. Barlow, J. Sybil Biermann, et al.. (2011). Reply to J.R. Gralow et al. Journal of Clinical Oncology. 29(26). 3592–3593. 1 indexed citations
17.
Poznak, Catherine Van, Sarah Temin, Gary C. Yee, et al.. (2011). American Society of Clinical Oncology Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer. 4 indexed citations
18.
Rutherford, George W., Jean Woo, Dan Neal, et al.. (1991). Partner Notification and the Control of Human Immunodeficiency Virus Infection. Sexually Transmitted Diseases. 18(2). 107–110. 21 indexed citations
19.
Farrell, Peter, et al.. (1972). Shock in acute pancreatitis and hypovolaemia.. PubMed. 13(10). 844–844. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026